Legal Reference

Psychedelic Medicine
Legal Status Guide

A comprehensive, up-to-date reference for the legal status of psychedelic medicines by country and US state. Laws change rapidly — always verify current status before traveling.

Last updated: May 2026

Legal / Regulated
Decriminalized
Clinical Trials
Legislation Pending
Illegal / Schedule I

Disclaimer: This information is for educational purposes only and is not legal advice. Laws change frequently. Always consult a legal professional and verify current laws before traveling or seeking treatment. Pō a Ao is not responsible for actions taken based on this information.

Ibogaine

US Federal Status: Schedule I — illegal federally in the US

Trump Executive Order (April 2026) created Right to Try pathway for veterans. Legal in Mexico, Brazil, New Zealand, South Africa, and Gabon.

Mexico

Legal and unregulated. Most US patients travel here. Rosarito, Tijuana, and Cancún are primary hubs.

Brazil

Legal since 1994. Used in addiction treatment clinics.

New Zealand

Approved as a prescription medicine for addiction treatment.

South Africa

Legal and used in addiction clinics.

Gabon

Traditional use of iboga root is a protected cultural practice.

Portugal

All drugs decriminalized for personal use. Ibogaine clinics operate legally.

Netherlands

Legal. Ibogaine clinics operate openly.

United States

Schedule I federally. Right to Try pathway for veterans created by Executive Order April 2026.

Canada

Schedule III. Some exemptions granted for clinical research.

United Kingdom

Class A controlled substance.

Psilocybin (Magic Mushrooms)

US Federal Status: Schedule I — illegal federally in the US

Oregon legalized therapeutic use in 2023. Colorado legalized in 2024. Australia approved for PTSD and depression in 2023. FDA Breakthrough Therapy designation.

Oregon, USA

Measure 109 — legal for therapeutic use at licensed service centers since 2023.

Colorado, USA

Proposition 122 — legal for therapeutic use and personal cultivation since 2024.

Australia

TGA approved for PTSD and treatment-resistant depression in 2023. Administered by authorized psychiatrists.

Netherlands

Psilocybin truffles are legal. Mushrooms are technically illegal but widely available.

Jamaica

Never scheduled. Legal and unregulated. Retreat centers operate openly.

Brazil

Not scheduled. Legal for personal use and ceremonial contexts.

Denver, CO

First US city to decriminalize (2019). Lowest enforcement priority.

Oakland/SF, CA

Decriminalized 2019. Lowest enforcement priority.

Washington DC

Initiative 81 — lowest enforcement priority since 2020.

Canada

Section 56 exemptions granted for therapeutic use. Decriminalized in some cities.

MDMA (Ecstasy)

US Federal Status: Schedule I — illegal federally in the US

MAPS Phase 3 trials showed 71.2% of veterans no longer met PTSD criteria. FDA review ongoing. Australia approved for PTSD in 2023.

Australia

TGA approved for PTSD in 2023. First country to approve MDMA-assisted therapy.

United States

FDA Breakthrough Therapy designation. Phase 3 trials complete. FDA review ongoing. Lykos Therapeutics application submitted.

Canada

Health Canada approved expanded access. Clinical trials ongoing.

Israel

Phase 2 trials for PTSD. Government-funded research.

United Kingdom

Phase 2 trials approved. Imperial College London research ongoing.

Netherlands

Clinical research ongoing.

Czech Republic

MDMA-assisted therapy trials approved.

Ketamine

US Federal Status: Schedule III — legal with prescription in the US

The only FDA-approved psychedelic-adjacent medicine. Spravato (esketamine) FDA-approved for treatment-resistant depression. Available at clinics in all 50 states.

United States

Schedule III. Legal at licensed clinics in all 50 states. Spravato (esketamine) FDA-approved for TRD and MDD with suicidal ideation. VA coverage expanding.

Canada

Legal with prescription. Ketamine clinics operating in major cities.

United Kingdom

Class B controlled substance but legal for medical use. Ketamine clinics operating.

Australia

TGA-approved for depression. Clinics operating in major cities.

European Union

Legal for medical use in most EU countries. Esketamine (Spravato) approved by EMA.

Ayahuasca (DMT + MAOIs)

US Federal Status: DMT is Schedule I. Ayahuasca brew is a legal gray area in the US.

Legal for religious use in the US under RFRA (Religious Freedom Restoration Act). Legal in Peru, Brazil, and several other countries. Retreat centers operate openly in many jurisdictions.

Peru

National cultural heritage. Legal and unregulated. Hundreds of retreat centers operate openly.

Brazil

Legal for religious use since 1987. Santo Daime and UDV churches operate globally.

Netherlands

Legal gray area. Retreat centers operate openly. DMT is illegal but ayahuasca brew is not explicitly scheduled.

Portugal

All drugs decriminalized for personal use. Retreat centers operate.

United States

DMT is Schedule I but ayahuasca has legal protection for religious use under RFRA. Several churches have won court cases.

Costa Rica

Legal and unregulated. Major retreat destination.

Colombia

Traditional use protected. Retreat centers operate openly.

Have Questions About
Legal Access?

Ask the AI for more detail on any jurisdiction, or call Sonny to discuss your specific situation and what options are available to you right now.